Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8166)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2017 (publication date) through Feb 27, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Reggiani Bonetti L, Lionti S, Domati F, Barresi V. Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery? World J Gastroenterol 2017; 23(8): 1412-1423 [PMID: 28293088 DOI: 10.3748/wjg.v23.i8.1412] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i8/1412.htm |
| Number | Citing Articles |
| 1 |
Yuma Wada, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Zhongxu Zhu, Xin Wang, Ane Etxart, Yangsoon Park, Luis Bujanda, In Ja Park, Ajay Goel. Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer. JCO Precision Oncology 2021; (5): 1788 doi: 10.1200/PO.21.00015
|
| 2 |
Xiaohui Xu, Zhiyuan Kong, Ke Yi, Bing Wang, Qingjun Lei, Yi Wang. Colonic mucinous adenocarcinoma causing intussusception and distant metastasis. Medicine 2019; 98(21): e15740 doi: 10.1097/MD.0000000000015740
|
| 3 |
Laura Bertoni, Valeria Barresi, Luca Reggiani Bonetti, Stefania Caramaschi, Alessandro Mangogna, Simona Lionti, Paola Azzoni, Gianluca Carnevale, Alessandra Pisciotta, Tiziana Salviato. Poorly differentiated clusters (PDC) in colorectal cancer: Does their localization in tumor matter?. Annals of Diagnostic Pathology 2019; 41: 106 doi: 10.1016/j.anndiagpath.2019.06.008
|
| 4 |
Sumana Narayanan, Kristopher Attwood, Emmanuel Gabriel, Steven Nurkin. Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer. Journal of Surgical Research 2020; 251: 220 doi: 10.1016/j.jss.2020.01.019
|
| 5 |
W. Cao, Z. Li, A. Mohamoud, J. Gong, X. Wang, J. Zhou, H. Hu, Y. Huang, W. Li, F. Li, D. Liu, C. Liang, Z. Zhou. Quantitative MRI assessment of mucinous rectal adenocarcinoma to predict tumour response after neoadjuvant therapy. Clinical Radiology 2019; 74(4): 278 doi: 10.1016/j.crad.2018.10.015
|
| 6 |
Yuho Ono, Justin M.M. Cates, Raul S. Gonzalez. Can histologic features predict neoadjuvant therapy response in rectal adenocarcinoma?. Pathology - Research and Practice 2021; 226: 153608 doi: 10.1016/j.prp.2021.153608
|
| 7 |
Dong-Lin Ren, Juan Li, Hui-Chuan Yu, Shao-Yong Peng, Wei-Da Lin, Xiao-Lin Wang, Roshan Ara Ghoorun, Yan-Xin Luo. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World Journal of Gastroenterology 2019; 25(1): 118-137 doi: 10.3748/wjg.v25.i1.118
|
| 8 |
Sare Hosseini, NamPhong Nguyen, Mohammad Mohammadianpanah, Sepideh Mirzaei, Ali Mohammad Bananzadeh. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study. Journal of Gastrointestinal Cancer 2019; 50(4): 716 doi: 10.1007/s12029-018-0136-x
|
| 9 |
Nicolas J. Llosa, Brandon Luber, Nicholas Siegel, Anas H. Awan, Teniola Oke, Qingfeng Zhu, Bjarne R. Bartlett, Laveet K. Aulakh, Elizabeth D. Thompson, Elizabeth M. Jaffee, Jennifer N. Durham, Cynthia L. Sears, Dung T. Le, Luis A. Diaz, Drew M. Pardoll, Hao Wang, Franck Housseau, Robert A. Anders. Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy. Cancer Immunology Research 2019; 7(10): 1574 doi: 10.1158/2326-6066.CIR-18-0927
|
| 10 |
Iris D. Nagtegaal, Rob Glynne-Jones. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treatment Reviews 2020; 84: 101964 doi: 10.1016/j.ctrv.2020.101964
|
| 11 |
Xiaoling Zhong, Guohua Zeng, Lixiang Zhang, Shuyuan You, Yuxiang Fu, Wan He, Guixiang Liao. Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1361300
|
| 12 |
Jesse Fischer, Tim W Eglinton, Simon JG Richards, Frank A Frizelle. Predicting pathological response to chemoradiotherapy for rectal cancer: a systematic review. Expert Review of Anticancer Therapy 2021; 21(5): 489 doi: 10.1080/14737140.2021.1868992
|
| 13 |
Qunsheng Huang, Huabo Qin, Jian Xiao, Xiaosheng He, Minghao Xie, Xin He, Qiuqiong Yao, Ping Lan, Lei Lian. Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy. Gastroenterology Report 2019; 7(4): 283 doi: 10.1093/gastro/goy045
|
| 14 |
Praveen S. Kammar, Niharika R. Garach, Sivasanker Masillamany, Ashwin de’Souza, Vikas Ostwal, Avanish P. Saklani. Downstaging in Advanced Rectal Cancers: A Propensity-Matched Comparison Between Short-Course Radiotherapy Followed by Chemotherapy and Long-Course Chemoradiotherapy. Diseases of the Colon & Rectum 2022; 65(10): 1215 doi: 10.1097/DCR.0000000000002331
|
| 15 |
Wuteng Cao, Lei Wu, Yandong Zhao, Jie Zhou, Wenli Li, Xinhua Wang, Jianbo Xu, Zhiyang Zhou, Changhong Liang. A New MRI-Defined Biomarker for Rectal Mucinous Adenocarcinoma: Mucin Pool Patterns in Determining the Efficacy of Neoadjuvant Therapy. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01425
|
| 16 |
Camille Raets, Chaïmae El Aisati, Amir L. Rifi, Mark De Ridder, Koen Putman, Johan De Mey, Alexandra Sermeus, Kurt Barbé. Optimizing Rectal Cancer Patient Care: Dworak TRG Prediction via Bayesian Evolutionary Fourier-Domain Random Subspace Forest. IEEE Transactions on Instrumentation and Measurement 2024; 73: 1 doi: 10.1109/TIM.2024.3365163
|
| 17 |
Mou Li, Yu-Zhou Zhu, Yong-Chang Zhang, Yu-Feng Yue, Hao-Peng Yu, Bin Song. Radiomics of rectal cancer for predicting distant metastasis and overall survival. World Journal of Gastroenterology 2020; 26(33): 5008-5021 doi: 10.3748/wjg.v26.i33.5008
|
| 18 |
Roger von Moos, Dieter Koeberle, Sabina Schacher, Stefanie Hayoz, Ralph C. Winterhalder, Arnaud Roth, György Bodoky, Panagiotis Samaras, Martin D. Berger, Daniel Rauch, Piercarlo Saletti, Ludwig Plasswilm, Daniel Zwahlen, Urs R. Meier, Pu Yan, Paola Izzo, Dirk Klingbiel, Daniela Bärtschi, Kathrin Zaugg. Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS -mutated rectal cancer: A phase I/II trial (SAKK 41/08). European Journal of Cancer 2018; 89: 82 doi: 10.1016/j.ejca.2017.11.005
|
| 19 |
Fang-Ze Wei, Shi-Wen Mei, Jia-Nan Chen, Zhi-Jie Wang, Hai-Yu Shen, Juan Li, Fu-Qiang Zhao, Zheng Liu, Qian Liu. Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy. World Journal of Gastroenterology 2020; 26(42): 6638-6657 doi: 10.3748/wjg.v26.i42.6638
|
| 20 |
Jyi Cheng Ng, Annaclara Sileo, Richard Sassun, Sara Aboelmaaty, Tommaso Violante, Ibrahim A. Gomaa, Anne-Lise D’Angelo, Kristen K. Rumer, Kellie L. Mathis, David W. Larson. Predictors of Pathologic Non-response to Neoadjuvant Approaches in Locally Advanced Rectal Cancer. Annals of Surgical Oncology 2025; doi: 10.1245/s10434-025-16962-1
|
| 21 |
Serena Ammendola, Nicolò Caldonazzi, Paola Chiara Rizzo, Giulia Turri, Corrado Pedrazzani, Valeria Barresi. H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma. Biomedicines 2022; 10(8): 2042 doi: 10.3390/biomedicines10082042
|
| 22 |
Yanwu Sun, Yiyi Zhang, Zhekun Huang, Pan Chi. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram. Journal of Gastrointestinal Surgery 2019; 23(5): 1006 doi: 10.1007/s11605-018-3942-3
|
| 23 |
Camille Raets, Chaïmae El Aisati, Amir L. Rifi, Mark De Ridder, Koen Putman, Johan De Mey, Alexandra Sermeus, Kurt Barbé. Bridging the Gap Between Machine Learning and Medicine: A Critical Evaluation of the Dworak Regression Grade in Rectal Cancer. IEEE Open Journal of Instrumentation and Measurement 2024; 3: 1 doi: 10.1109/OJIM.2024.3478314
|
| 24 |
Rahul Rajagopal, Renu Sukumaran, ChoondalDevan Sivanandan, Jayasree Katoor. Histopathological assessment of rectal carcinomas after neoadjuvant chemoradiotherapy. Clinical Cancer Investigation Journal 2021; 10(4): 196 doi: 10.4103/ccij.ccij_135_20
|
| 25 |
Rory F. Kokelaar, Huw G. Jones, Jeremy Williamson, Namor Williams, A. Paul Griffiths, John Beynon, Gareth J. Jenkins, Dean A. Harris. DNA hypermethylation as a predictor of extramural vascular invasion (EMVI) in rectal cancer. Cancer Biology & Therapy 2018; 19(3): 214 doi: 10.1080/15384047.2017.1416933
|
| 26 |
Luca Reggiani Bonetti, Simona Lionti, Federica Domati, Giuliana Pagliani, Elisabetta Mattioli, Valeria Barresi. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy. Histopathology 2017; 71(3): 393 doi: 10.1111/his.13242
|
| 27 |
Ian S. Reynolds, Emer O’Connell, Michael Fichtner, Elaine W. Kay, Deborah A. McNamara, Jochen H.M. Prehn, John P. Burke. Mucin Pools Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. American Journal of Surgical Pathology 2020; 44(2): 280 doi: 10.1097/PAS.0000000000001373
|